Outcomes following percutaneous coronary intervention in patients with cancer.

ABSTRACT:

Background

Randomized clinical trials demonstrated the benefits of percutaneous coronary interventions (PCI) in diverse clinical settings. Patients with cancer were not routinely included in these studies.

Methods/results

Literature search of PubMed, Cochrane, Medline, SCOPUS, EMBASE, and ClinicalTrials was conducted to identify studies that assessed one-year all-cause, cardiovascular and non-cardiovascular mortality in patients with historical or active cancer. Using the random effects model, we computed risk ratios (RRs) and standardized mean differences and their 95% confidence intervals for the dichotomous and continuous measures and outcomes, respectively. Of 171 articles evaluated in total, 5 eligible studies were included in this meta-analysis. In total, 33,175 patien

SUBMITTER: Quintana RA 

PROVIDER: S-EPMC7924730 | biostudies-literature | 2020 Feb

REPOSITORIES: biostudies-literature